Eversept Partners, LP
- SEC CIK
- 0001697013
- Latest filing
- Aug 14, 2026
Holdings in Q2 2026
Holdings as of Jun 30, 2026, filed Aug 14, 2026. Long positions only; changes compare share counts with Q1 2026.
- Positions
- 115
- +11 vs. Q1 2026
- Portfolio value
- $1.83B
- +$316.9M (+20.9%) vs. Q1 2026
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| LQDALiquidia Corp | COM NEW | 428,652 | $34.2M | 1.9% | −248,740−36.7% | Reduced | History |
| PCVXVaxcyte, Inc. | COM | 629,952 | $36.6M | 2.0% | −294,241−31.8% | Reduced | History |
| HCAHCA Healthcare, Inc. | COM | 98,252 | $38.3M | 2.1% | +19,023+24.0% | Added | History |
| CTRECareTrust REIT, Inc. | COM | 1,072,015 | $43.3M | 2.4% | +1,072,015 | New | History |
| TVTXTravere Therapeutics, Inc. | COM | 798,973 | $45.4M | 2.5% | +256,363+47.2% | Added | History |
| NTRANatera, Inc. | COM | 175,807 | $47.7M | 2.6% | −208,906−54.3% | Reduced | History |
| IONSIonis Pharmaceuticals Inc | COM | 664,684 | $52.7M | 2.9% | +32,584+5.2% | Added | History |
| BKDBrookdale Senior Living Inc. | COM | 3,396,470 | $54.6M | 3.0% | −172,085−4.8% | Reduced | History |
| SNDXSyndax Pharmaceuticals Inc | COM | 2,798,210 | $61.2M | 3.3% | −87,412−3.0% | Reduced | History |
| CLDXCelldex Therapeutics, Inc. | COM NEW | 1,785,941 | $66.5M | 3.6% | −2,075−0.1% | Reduced | History |
| VERAVera Therapeutics, Inc. | CL A | 2,212,770 | $94.9M | 5.2% | +39,484+1.8% | Added | History |
| ENSGEnsign Group, Inc | COM | 602,079 | $96.5M | 5.3% | +587,318+3,978.8% | Added | History |
| EHCEncompass Health Corp | COM | 1,026,919 | $103.8M | 5.7% | +832,815+429.1% | Added | History |
| ABVXAbivax S.A. | SPONSORED ADS | 913,880 | $121.8M | 6.6% | −20,543−2.2% | Reduced | History |
| UTHRUnited Therapeutics Corp | COM | 287,668 | $155.9M | 8.5% | +23,397+8.9% | Added | History |
Options (5)
Puts and calls in the same filing. Amounts are the market value of the underlying shares, which is what 13F reports.
Sold out since Q1 2026 (20)
Positions held at the end of Q1 2026 that are gone from this filing.
| Security | Class | Shares in Q1 2026 | Value in Q1 2026 | % of portfolio in Q1 2026 | History |
|---|---|---|---|---|---|
| DOCHealthpeak Properties, Inc. | COM | 1,981,070 | $32.5M | 2.1% | History |
| AVTRAvantor, Inc. | COM | 2,974,287 | $23.3M | 1.5% | History |
| QGENQiagen N.V. | ORD SHARES | 545,330 | $21.8M | 1.4% | History |
| ICLRIcon PLC | COM | 68,688 | $7.60M | 0.5% | History |
| AGIOAgios Pharmaceuticals, Inc. | COM | 200,000 | $6.77M | 0.4% | History |
| MDGLMadrigal Pharmaceuticals, Inc. | COM | 10,000 | $5.23M | 0.3% | History |
| ESPREsperion Therapeutics, Inc. | COM | 1,735,963 | $4.76M | 0.3% | History |
| HQYHealthequity, Inc. | COM | 51,614 | $4.31M | 0.3% | History |
| DAWNDay One Biopharmaceuticals, Inc. | Stock | 183,902 | $3.94M | 0.3% | History |
| CNCCentene Corp | Stock | 111,652 | $3.66M | 0.2% | History |
| EHABEnhabit, Inc. | COM | 227,451 | $3.20M | 0.2% | History |
| STROSutro Biopharma, Inc. | COM SHS | 73,161 | $1.82M | 0.1% | History |
| NVCRNovoCure Ltd | ORD SHS | 134,917 | $1.47M | 0.1% | History |
| BVSBioventus Inc. | COM CL A | 159,110 | $1.45M | 0.1% | History |
| IMCRImmunocore Holdings plc | ADS | 39,238 | $1.18M | 0.1% | History |
| TYRATyra Biosciences, Inc. | COM | 27,055 | $1.04M | 0.1% | History |
| PASGPassage BIO, Inc. | COM | 131,581 | $1.03M | 0.1% | History |
| DHCDiversified Healthcare Trust | COM SH BEN INT | 151,283 | $1.00M | 0.1% | History |
| INMDInMode Ltd. | SHS | 67,744 | $926.7K | 0.1% | History |
| AIRSAirsculpt Technologies, Inc. | COM | 74,139 | $209.8K | <0.1% | History |